drugset / Trial / NCT02481947
A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate a daily dose of BLI400 Laxative for safety and efficacy versus lubiprostone in constipated adults.
Timeline
- Start
- 2015-05
- Primary completion
- 2015-11
- Completion
- 2015-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BLI400 Laxative | Unknown | 21 g | — |
| Comparator | Lubiprostone | Small molecule | 24 ug | — |